ABSTRACT
BACKgRound
Subarachnoid haemorrhage (SAH) is a rare, potentially fatal cause of headache. Classically, the patient will present with a sudden onset, severe headache and meningeal signs and/or altered consciousness. One important and treatable cause of SAH is an underlying, contained, ruptured cerebral berry aneurysm. These berry aneurysms require treatment to prevent recurrent SAH, because further bleeds can be more substantial, more disabling, potentially untreatable and fatal. 1, 2 The initial investigation for clinically suspected SAH is unenhanced computed tomography (CT). This has a sensitivity of 91-98% which decreases with time from onset of symptoms. 3, 4 In many institutions, if SAH is detected on CT, then CT angiography (CTA) is the next line investigation to identify and characterise berry aneurysms with a view to treatment.
Lumbar puncture (LP) is performed in those in whom SAH is suspected clinically but who have normal unenhanced CT results. 5 Subarachnoid blood is broken down into bilirubin, which produces a visible yellow discolouration of cerebrospinal fluid (CSF) known as xanthochromia. This is measured with high sensitivity using spectrophotometry. 6 Patients found to have CSF evidence of SAH often undergo CTA with a view to defining size, number and potential treatability of the berry aneurysms.
Not all patients with CSF xanthochromia have aneurysms; 7 and it is not proven that patients with a positive LP, normal unenhanced CT and normal CTA require further catheter angiographic follow-up. Patients who have been followed up by catheter angiography are sometimes reported as subsets of larger studies. Kershenovich et al. 8 reported eight patients followed up by catheter angiography. Westerlaan et al. 9 reported 13 patients, of whom 12 were followed up with digital subtraction angiography (DSA) and one with repeat CTA. Agid et al. 10 followed up 32 patients and found one case of vasculitis on DSA, which was retrospectively visible on CTA. Similarly, others reported 16 patients, 11 two patients 12 and 27 patients. 13 Thus no aneurysms were identified in a total of 98 patients. No studies were found in which CT and CTA negative but CSF positive patients were the sole subject of investigation.
Catheter angiography is regarded as a gold standard. However, it has a risk of neurological and other complications. A report on 2,899 patients between 1996 and 2001 14 noted a 1.3% risk of neurological complications and a 0.5% risk of permanent neurological complications. Fifi et al. 15 reported no neurological complications in 3,636 patients who had diagnostic angiograms performed only by interventional neuroradiologists in an academic centre. These high-volume centres, performing approximately 500 procedures per year, gain experience which is not achievable in less densely populated areas; and experience is decreasing as noninvasive vascular imaging improves. Clinically undetectable brain ischaemia may be revealed by diffusion-weighted imaging in 11-26% of patients undergoing diagnostic cerebral angiography. Although the clinical significance of such 'silent' ischaemic lesions is debated, there is evidence that the cumulative burden of ischaemic lesions results in neuropsychological deficits or vascular dementia. 20 The study by Fifi et al. identified one femoral abscess, two femoral occlusions with leg ischaemia requiring surgical revascularisation, one dissecting pseudo-aneurysm requiring thrombin injection and one retroperitoneal haematoma requiring transfusion, 15 emphasising that non-neurological complications may be serious.
Given the risks of catheter angiography and uncertainty as to whether it is necessary in the sub-group of patients with normal unenhanced CT and CTA, but positive CSF spectrophotometry, we aimed to determine if this group of patients still warrants the risk of catheter angiography in the context of modern CT imaging.
MeThodS
The institutional ethics committee considered that this retrospective study was a clinical audit and therefore did not require ethical approval. However, the departmental data protection officer advised that all patient data should be fully anonymised.
A search of the clinical biochemistry laboratory information system (APEX, iSOFT plc, Banbury, UK) yielded data on all CSF samples positive for haemoglobin breakdown products (analysed using the UvikonXL spectrophotometer, Northstar Scientific, Leeds, UK).
Analysis and reporting were performed in accordance with the UK National External Quality Assessment Service (NEQAS) national guidelines. Net bilirubin absorbance was measured at 476 nm; an absorbance of ≤0.007 AU indicated that bilirubin was not raised. Likewise, a net oxyhaemoglobin absorbance of ≤0.02 AU indicated that oxyhaemoglobin was not raised. 6 Patients who had positive spectrophotometry were individually searched on the radiology information system. All images and reports were reviewed, as were the electronic discharge summaries for CTA negative patients. The majority of CT angiograms were performed in Aberdeen Royal Infirmary using a 128-multidetector Siemens Definition (Erlangen, Germany) scanner. A minority of CT angiograms were performed in hospitals with 64-multidetector Toshiba Aquilion (Tokyo, Japan) and on 40-multidetector Philips Brilliance (Best, Netherlands) scanners.
Patients were excluded if there was a known haemorrhage on unenhanced CT or if neurovascular imaging had not been performed. For the purposes of this study, patients with insufficient CSF samples or in whom oxyhaemoglobin levels impaired ability to detect bilirubin were not regarded as LP positive.
ReSulTS
A total of 316 CSF samples were analysed by spectrophotometry between 1 February 2011 and 31 January 2012. There were 26 patients with bilirubin detected by spectrophotometry which was not accounted for by increased serum bilirubin. Figure 1 shows a breakdown of the samples included in this study.
The excluded patients with known haemorrhage included one post-neurosurgical patient who was being investigated for meningitis, one patient with known contusions who was being investigated for meningitis, one pregnant patient with intracerebral haemorrhages secondary to eclampsia and one patient with a perimesencephalic haemorrhage (the latter patient had CTA performed). One patient with encephalitis and one patient with malignant meningitis secondary to breast cancer had no vascular imaging performed. In five patients the reason for not proceeding to vascular imaging was unclear. Of the remaining 15 patients, six had aneurysms detected by the radiologist on the first CT angiogram. This left nine patients with a negative unenhanced CT, positive CSF spectrophotometry and an apparently normal first CT angiogram. These are presented in Table 1 . All but two of the patients were imaged in Aberdeen Royal Infirmary.
One 75-year-old patient did have aneurysms missed on CT cerebral angiography which were identified on a Spectrophotometry positive CTA negative subarachnoid haemorrhage later noninvasive CT angiogram of the neck. These aneurysms were retrospectively visible on the initial CT cerebral angiography (Figure 2 ). The sac diameters were 2 mm and 3 mm, and they were deemed not to be causative after multi-disciplinary review. This patient was also imaged on the 128-multidetector CT scanner. CSF= cerebrospinal fluid; CTA= computed tomography angiography; DSA= digital subtraction angiography; LP= lumbar puncture; SAH= subarachnoid haemorrhage. 23 or 3% for xanthochromic index. 24 Our cases confirm that positive CSF spectrophotometry occurs in haemorrhagic conditions such as contusions, recent neurosurgery, difficult traumatic LP, perimesencephalic haemorrhage and also in other conditions such as encephalitis and malignant meningitis. In a study using DSA, 25 the clinical diagnoses in those without aneurysms were traumatic SAH, sickle-cell disease, HIV positive with varicella, migraine and systemic lupus erythematosus plus antiphospholipid syndrome. In a significant proportion of cases the cause of haemoglobin breakdown products was not identified; 25 however, the outcome was favourable in these patients. 26 Our patients who had spectrophotometric evidence of xanthochromia and no vascular imaging suggest that CSF biochemistry was performed when not required or that a diagnosis other than SAH was regarded as more likely.
Initial angiography by invasive DSA was not the subject of this study. There are several such studies in patients with no abnormality on CT, and LP-diagnosed haemorrhage. Rinkel et al. 28 reported three patients who did well on clinical follow-up. Jung et al. 29 reported 12 patients, all of whom had no significant resultant disability; also, no abnormality was found in the one patient who had a second catheter angiogram. Topcuoglu et al. 26 did not find the cause of haemorrhage in nine patients. Almandoz et al. 30 reported five CSF xanthochromia patients who had a negative initial catheter angiogram and no causative aneurysm on follow-up CTA and magnetic resonance angiography (MRA). Our study focused on the use of CTA as the initial vascular imaging. In cases where SAH is conspicuous on unenhanced CT, it is already known that aneurysms may be missed on CTA if they are small, or if they are multiple aneurysms, 31 close to bone, 11 or due to arterial spasm. 10 Where SAH is not visible on unenhanced CT, this limitation of CTA seemed not to apply. 10, 11 Agid et al. 10 and Kelliny et al. 11 concluded that CTA without confirmatory catheter angiography (DSA) may be sufficient to exclude ruptured aneurysms for patients without any haemorrhage on plain CT. The strategy of avoiding DSA is gaining acceptance in perimesencephalic SAH, 8, 10, 11 and a similar change may occur in CT negative, LP positive and CTA negative patients. The enthusiasm for invasive vascular imaging varies between clinicians, units and countries and is also changing over time as the quality of noninvasive vascular imaging improves. In one of our patients two very small aneurysms were missed on initial reading by the radiologist on the CT angiogram. These aneurysms, considered to be incidental, were not treated (Figure 2 ).
Intracavernous aneurysms generally exhibit a benign clinical course. Rupture leads to carotido-cavernous fistulae and rarely, SAH. 32, 33 The ones treated in the van Rooij study had a mean size of 10 mm if treated by coil embolisation, 21 mm if treated by occlusion and 27 mm if treated by bypass. 33 This compares to 2 mm in our case.
The paraclinoid location is common in patients with unruptured intracranial aneurysms. However, they represent only 1.4-9.1% of patients with ruptured aneurysms. 27 The patients with SAH treated by Loumiotis et al. had aneurysms with a mean fundus size of 8 mm, 79% of which were less than 10 mm. 27 This compares with 3 mm in our case.
Aneurysms close to bone have a known risk of being missed. Our case resembles the cases published by Kelliny et al. 11 and Agid et al. 10 Those cases were in the context of CT visible SAH, whereas our case differs in the context of no haemorrhage visible on CT.
Measures to detect aneurysms in apparently negative CTA cases include double reporting of CT angiograms, DSA, repeat CT angiography and follow-up MRA.
FiguRe 2
Missed aneurysms on CT angiography. The internal carotid artery segments are labelled according to the embryonic segments described by Lasjaunias and Santoyo-Vazquez and updated by Gailloud et al. 36 The ascending cavernous aneurysm measures 2 x 2 mm and the clinoid aneurysm measures 5 x 3 mm.
Review of our false-negative CT shows that the aneurysms were visible on the initial CTA. Double-reporting of 'normal' CT angiograms may therefore detect the oversight, a strategy that would require no additional patient attendances. This depends on the second radiologist being attuned to the likely sites of missed aneurysms. Invasive angiography would also have detected these aneurysms. However, as our patient did not require treatment it is inappropriate to recommend DSA, with its attendant risks. Magnetic resonance angiography is a possible noninvasive follow-up modality. Like DSA, it does not have the difficulty of distinguishing aneurysm from bone, but unlike DSA there is no risk of vascular injury.
Digital subtraction angiography is regarded as the gold standard for excluding vascular pathologies, and avoiding DSA may have disadvantages. DSA may allow vasculitis to be shown as found by Agid et al. 10 and the sequential images demonstrate abnormal flow through arteriovenous malformations (although a delayed repeat DSA may be required to show a small lesion 34 ). Another consequence of avoiding DSA is that experience of the procedure may be insufficient to maintain operator competence.
Where does the balance lie between the risk of DSA (and its cost) and that of missing a significant berry aneurysm? The number of patients studied here and elsewhere remains small, limiting any firm conclusions. Others have suggested that, in perimesencephalic haemorrhage, CT angiography alone is the best diagnostic strategy. 35 However, this is not yet agreed practice in CT normal suspected SAH.
liMiTATionS of ThiS STudy
Our review is limited by the small number of patients found to be CT negative, LP positive and CTA negative, reflecting the rarity of this clinical scenario which has, in turn, led to the small numbers of patient cases published elsewhere. Our study does not consider other potential causes of occult SAH such as vasculitis or reversible cerebral vasoconstriction syndrome. Only three of our nine patients had DSA and this may reflect a change in practice away from DSA. Furthermore, the retrospective nature of this review and clinical review limited to discharge letters meant that the study of clinical information on individual patients was limited. A larger, collaborative, multi-disciplinary, prospective study would benefit our understanding of this type of occult SAH.
ConCluSion
The risk of missing a clinically significant aneurysm is low in patients with a normal unenhanced CT, CSF spectrophotometry positive for haemoglobin breakdown products and a negative CTA.
